tiprankstipranks
Staar Surgical price target raised to $79 from $76 at Canaccord
The Fly

Staar Surgical price target raised to $79 from $76 at Canaccord

Canaccord analyst William Plovanic raised the firm’s price target on Staar Surgical to $79 from $76 and keeps a Buy rating on the shares. The analyst met with management for a fireside chat and he believes investors are focused mostly on China and the US launch including barriers to adoption such as facilities and overcoming the mindset that EVO is a niche product. He believes the company has a gameplan and possibly regulatory tailwinds to continue to garner market share in the United States and worldwide.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on STAA:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles